DNP 810 Refer to the complex inheritance health issue identified in DQ 1
Grand Canyon University DNP 810 Refer to the complex inheritance health issue identified in DQ 1-Step-By-Step Guide
This guide will demonstrate how to complete the Grand Canyon University DNP 810 Refer to the complex inheritance health issue identified in DQ 1 assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
Whether one passes or fails an academic assignment such as the Grand Canyon University DNP 810 Refer to the complex inheritance health issue identified in DQ 1 depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
The introduction for the Grand Canyon University DNP 810 Refer to the complex inheritance health issue identified in DQ 1 is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
Need a high-quality paper urgently?
We can deliver within hours.
How to Write the Body for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
After the introduction, move into the main part of the DNP 810 Refer to the complex inheritance health issue identified in DQ 1 assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the DNP 810 Refer to the complex inheritance health issue identified in DQ 1 assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
Sample Answer for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
Re: Topic 2 DQ 2
Researchers are learning to predict people’s chances of developing diabetes. For instance, most white people with type 1 diabetes have genes associated with autoimmune diseases. Suppose their child is white and shares those genes, their child’s risk increases (McCarthy, 2019). Suspect genes in other ethnic groups are less well studied; however, scientists believe that the gene may also put African Americans in danger. One screening involves an antibody test for children with type 1 diabetic brothers and sisters. The test measures antibodies against insulin, islet cells, and an enzyme called glutamic acid decarboxylase (GAD). Elevated rates may suggest a child has a higher risk of developing type 1 diabetes. An additional genetic test for monogenic diabetes is to provide a blood or saliva sample from the DNA. The DNA analyzes changes in the genes that cause monogenic diabetes (Pinto et al., 2021). Abnormal results can determine the gene responsible for diabetes in a particular person or show if a person is likely to develop a monogenic form of diabetes in the future. Genetic testing can help select the most suitable therapy for people with monogenic diabetes. Also, understanding the risk of having a child with monogenic diabetes is critical in pregnancy planning. Nurses trained DNP’s are able to apply the knowledge of genetic tests through diagnosis, disease prognosis, treatment, and advice.
Reference
McCarthy, J. (2019, May 23). How genetic testing is benefiting patients with diabetes. Precision Medicine Advisors. Retrieved June 21, 2022, from https://www.precisionmedicineadvisors.com/precisionmedicine-blog/2019/4/30/how-genetic-testing-is-benefiting-patients-with-diabetes
Pinto, D. L., De Araújo, R., Cruz, S. A., Canavarro, T. A., & Brito, M. A. (2021). Diabetes monogênico: Diabetes tipo mody, diabetes neontal / monogenic diabetes: Mody diabetes, neonatal diabetes. Brazilian Journal of Development, 7(12), 114188–114205. https://doi.org/10.34117/bjdv7n12-276
Sample Answer 2 for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
Sickle cell disease (SCD) is one of the complex inheritance health issues that result from the presence of a mutated form of hemoglobin, hemoglobin S (HbS). The inheritance of the mutation can be homozygous or heterozygous in conjunction with another hemoglobin mutation (Sanyaolu et al., 2020). Screening for HbS after delivery is currently mandatory in the United States. It is a case-finding method that enables providers to initiate early treatment and control.
Hemoglobin electrophoresis is one of the available genetic tests I would use to screen and diagnose individuals with SCD. This chromatography technique is one of the important diagnostic tests used to detect Hb variants (Arishi et al., 2021). An electrical field is applied to aid the movement of electrically charged molecules. Various pH and mediums are used, either cellulose acetate electrophoreses at alkaline pH or citrate agar at acidic pH, which help identify hemoglobin variants.
Hemoglobin electrophoresis distinguishes persons who are homozygous for HbS from heterozygous. It confirms the diagnosis of SCD by showing a single band of HbS (in HbSS) or HbS with another mutant hemoglobin in compound heterozygotes (Arishi et al., 2021). If the electrophoresis results show only HbS with an HbF concentration below 30%, the diagnosis is sickle cell anemia for children with normocytic hemolytic anemia. However, if HbS and HbC are found almost equal amounts, the diagnosis is HbSC.
The DNP-prepared nurse can apply the information on SCD screening by recommending the Hemoglobin electrophoresis test to newborns. The screening results can help the DNP identify the appropriate treatment interventions and provide health education to parents on how the child will be managed, thus reducing mortality rates (Brandow et al., 2022). The DNP can also use the test to detect the Hb variants present in the patients and use the results to make a diagnosis and develop treatment plans.
References
Arishi, W. A., Alhadrami, H. A., & Zourob, M. (2021). Techniques for the detection of sickle cell disease: a review. Micromachines, 12(5), 519. . https://doi.org/10.3390/mi12050519
Brandow, A. M., & Liem, R. I. (2022). Advances in the diagnosis and treatment of sickle cell disease. Journal of hematology & oncology, 15(1), 20. https://doi.org/10.1186/s13045-022-01237-z
Sanyaolu, A., Agiri, E., Bertram, C., Brookes, L., Choudhury, J., Datt, D., Ibrahim, A., Maciejko, A., Mansfield, A., Nkrumah, J., & Williams, M. (2020). Current modalities of sickle cell disease management. Blood science (Baltimore, Md.), 2(4), 109–116. https://doi.org/10.1097/BS9.0000000000000056
Sample Answer 3 for DNP 810 Refer to the complex inheritance health issue identified in DQ 1
Down syndrome screening can undergo enactment within eleven through fourteen weeks of one’s pregnancy when addressing both blood examinations as well as ultrasounds within the first trimester (Lou et al., 2018). A blood test called the multiple marker serum screening tests can also be performed between 15 and 20 weeks. However, amniocentesis, chorionic villus sampling (CVS), and ultrasound are the primary diagnostic testing procedures employed primarily for the identification of chromosomal abnormalities, namely Trisomy 21 (Lou et al., 2018). DNA blood test ‘with additionally “accur[acy” for the detection of Trisomy 21 in comparison of conventional procedures dealing within a study of approximately “sixteen thousand pregnant women”, researchers investigated that a cell-free DNA blood test enacted within the timeframe of ten to fourteen weeks within the pregnancy proved higher within efficacy in regards to Down syndrome diagnosis (Lou et al., 2018).
Diagnostic tests identifying Down syndrome include Chorionic villus sampling (CVS) (Palomaki et al., 2020). Within CVS, placenta cells are extracted to analyze the fetal chromosomes (Palomaki et al., 2020). This examination is enacted within the first trimester of one’s pregnancy, identified as ten through thirteen weeks. Moreover, pregnancy risks of losing a pregnancy (miscarriage) from a CVS rests at a lowered probability-. Next, a sample of the amniotic fluid surrounding the fetus is withdrawn through a needle inserted into the mother’s uterus (Palomaki et al., 2020). This sample is later employed to analyze the fetus’s chromosomes (Palomaki et al., 2020). Doctors conventionally enact this test in the second trimester, after 15 weeks of pregnancy. This test also carries a shallow potentiality in regards to miscarriage. Additionally, preimplantation genetic diagnosis is an option for couples undergoing in vitro fertilization at an increased risk of passing along certain genetic conditions (Palomaki et al., 2020). Finally, the embryo is tested for congenital abnormalities before it’s implanted in the womb.
The importance of DNP-prepared nurses providing education on the benefits of partaking in genetic testing or diagnostic testing is that knowing the information in advance can help parents prepare themselves for a baby with special needs (Ostermaier, 2019). Genetic screening serves to determine whether individuals are a carrier regarding specific conditions of inheritance. To further demonstrate, most individuals are carriers of one or more genetic ailments, despite the rest of the carrier’s family lacking the presence of this particular condition. Being a carrier is essential if the person using the sperm is also a carrier of the same condition. However, these tests slightly increase the risk of miscarriage and other pregnancy complications. On the other hand, a positive result can direct a person toward available prevention, monitoring, and treatment options (Lou et al., 2018). Some test results can also aid people in their decisions about having children.
References
Lou, S., Petersen, O. B., Jørgensen, F. S., Lund, I. C., Kjaergaard, S., Danish Cytogenetic Central Registry Study Group, … & Hansen, J. F. (2018). National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973–2016 in Denmark. Acta Obstetricia et Gynecologica Scandinavica, 97(2), 195-203.
Ostermaier, K. K. (2019). Patient education: Down syndrome (Beyond the Basics).
Palomaki, G. E., Chiu, R. W., Pertile, M. D., Sistermans, E. A., Yaron, Y., Vermeesch, J. R., … & Wilkins-Haug, L. (2020). International Society for Prenatal Diagnosis Position Statement: cell free (cf) DNA screening for Down syndrome in multiple pregnancies. Prenatal Diagnosis, 41(10).